首页> 外国专利> PROCESS FOR ENZYMATIC DECOMPOSITION OF RECOMBINANT PROTEINS BY MEANS OF IGA-PROTEASE, FUSED PROTEIN, RECOMBINANT DNA, CELL

PROCESS FOR ENZYMATIC DECOMPOSITION OF RECOMBINANT PROTEINS BY MEANS OF IGA-PROTEASE, FUSED PROTEIN, RECOMBINANT DNA, CELL

机译:利用Iga蛋白酶,融合蛋白,重组DNA,细胞对重组蛋白进行酶解的方法

摘要

A method is claimed for prepg. proteins or peptides without a terminal methionine gp. from peptides and proteins with the sequence Met-Y-X-Pro-A (I), where X = Thr, Ala or Ser; Y = an amino acid sequence contg. at least two residues, which ends with the sequence Pro (or when X = Ser) can end with Pro-Ala-Pro; A = a further amino acid sequence. The method involves transforming a prokaryotic cell with a recombinant DNA and/or a recombinant vector coding for (I). The transformed cell is cultivated and the Met-Y-X-Pro-A is recovered from the medium, and cleaved with an IgA protease. The first cleavage prod., a G-CSF deriv. which has the sequence X-Pro-A, is isolated. Also claimed is the recombinant G-CSF itself and medicaments contg. it. USE/ADVANTAGE - The X-Pro-A produced has no N-terminal methionine; such peptides are difficult to synthesise by prior methods. It is a G-CSF deriv. useful for treatment of cancer and leukaemia, in bone marrow transplants, and for treating burns and opportunistic infections affecting patients with weakened immune systems.
机译:要求保护一种方法。没有末端蛋氨酸gp的蛋白质或肽。来自具有序列Met-Y-X-Pro-A(I)的肽和蛋白质,其中X = Thr,Ala或Ser; Y =连续的氨基酸序列。至少两个以Pro序列(或当X = Ser)终止的残基可以以Pro-Ala-Pro终止; A =另一个氨基酸序列。该方法包括用重组DNA和/或编码(I)的重组载体转化原核细胞。培养转化的细胞,并从培养基中回收Met-Y-X-Pro-A,并用IgA蛋白酶切割。第一个裂解产物,G-CSF衍生物。分离出具有序列X-Pro-A的序列。还要求保护的是重组G-CSF本身和药物。它。使用/优点-产生的X-Pro-A没有N端蛋氨酸;此类肽难以通过现有方法合成。它是G-CSF派生的。可用于在骨髓移植中治疗癌症和白血病,以及治疗烧伤和机会性感染,影响免疫系统较弱的患者。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号